Machine learning model for early diagnosis of breast cancer based on PiRNA expression with CA153

  • 0Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jiyan Road 440#, Jinan, 250117, Shandong, PR China.

|

|

Summary

This summary is machine-generated.

Circulating PIWI-interacting RNAs (piRNAs) show promise for early breast cancer detection. A machine learning model combining a tri-piRNA signature with CA153 achieved superior diagnostic accuracy.

Area Of Science

  • Molecular Biology
  • Oncology
  • Bioinformatics

Background

  • PIWI-interacting RNAs (piRNAs) play roles in cancer development.
  • Circulating piRNAs are potential biomarkers for cancer detection.

Purpose Of The Study

  • To investigate the diagnostic utility of circulating piRNAs for breast cancer (BC).
  • To develop and validate machine learning (ML) models for early BC diagnosis using piRNA signatures and clinical factors.

Main Methods

  • Serum piRNA sequencing identified a tri-piRNA signature (piR-139966, piR-2572505, piR-2570061).
  • Quantitative PCR (qPCR) validated piRNA expression levels.
  • Machine learning algorithms were employed to build predictive models integrating piRNA data with CA153 levels.

Main Results

  • The identified tri-piRNA signature was significantly upregulated in early-stage BC patients.
  • The piRNA panel enhanced diagnostic precision for BC detection, complementing CA153.
  • An XGBoost-based ML model integrating piRNA expression and CA153 demonstrated optimal performance for early BC identification.

Conclusions

  • Circulating piRNAs represent a promising biomarker for non-invasive early breast cancer diagnosis.
  • Machine learning frameworks can effectively integrate multi-modal data (piRNAs and CA153) for improved BC diagnostic accuracy.